Close Menu

You may find more results for this query on our sister sites: GenomeWeb and 360Dx.

Home › About Us › Our Staff › Turna Ray

Turna Ray

Managing Editor, Precision Oncology News
Phone Number
+1-212-651-5626
Email
[email protected]
Turna Ray at Genomeweb / 360dx Turna Ray at Genomeweb / 360dx

Turna Ray has been covering the personalized medicine and molecular diagnostics industries for GenomeWeb since 2006. She closely tracks the evolving regulatory, reimbursement, and business environment for precision medicine products. 

Articles Authored by Turna Ray

Jan 05, 2021

Precision Oncology in 2020: Pandemic Lessons, Biomarker Controversies, Community Access Gaps

Premium

Although a record number of new precision oncology drugs came to market, the pandemic further exposed access gaps that the field is focused on mitigating.

Dec 22, 2020

Genetic Testing Challenges in Oncology: Woman Without High Breast Cancer Risk Recommended Surgery

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.

Dec 10, 2020

Exact Sciences Oncotype DX Identifies Postmenopausal Breast Cancer Patients Who Can Forgo Chemo

Premium

The results, presented at SABCS this week, leave open whether the added benefit from chemo seen in premenopausal women may be due to chemo-induced hormone reduction.

Dec 08, 2020

ASH Studies Show Predictive Power of Undetectable MRD in Fixed-Duration CLL Regimens

Premium

Researchers presented data exploring CLL patients' outcomes on fixed-duration combination regimens and on using uMRD to decide which patients can stop treatment.

Dec 06, 2020

Lymphoma Patients With Aberrant CD58 Don't Derive Durable CAR T-cell Benefit, Study Shows

Premium

With improved understanding of the role of this biomarker, Stanford researchers hope to advance a next-generation CAR that can overcome resistance.

Dec 02, 2020

Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement

Premium

The companies will work with labs to improve payors' understanding of the costs of performing PD-L1 testing and the value it provides to patient care.

Nov 25, 2020

Genetic Testing Challenges in Oncology: BRCA2-Positive Healthy Young Man Recommended Mastectomy

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.

Nov 04, 2020

Survey of Precision Oncology Programs Shows Continued Adoption, Though 'Success' Metrics Unclear

Cancer centers are investing in testing and decision support tools to personalize cancer care, though the COVID-19 pandemic has presented challenges.

Oct 22, 2020

Genetic Testing Challenges in Oncology: Surgeon Recommends Mastectomy for Woman With RAD50 Mutation

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.

Oct 14, 2020

NCI-MATCH Data Shows Value of Platform Trials for Patients With Rare Genomically Driven Cancers

Premium

The findings demonstrate the value of multi-cohort platform trials as an option for refractory cancer patients with particularly rare genomic tumor alterations.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.